The preoperative systemic immune-inflammation index is associated with an unfavorable prognosis for patients undergoing curative resection of esophageal squamous cell carcinoma after neoadjuvant therapy

• Published in: Surgery today (Tokyo, Japan) Vol. 53; no. 8; pp. 964 - 972
• Main Authors: Obata, Yuma, Kanda, Mitsuro, Shimizu, Dai, Takami, Hideki, Inokawa, Yoshikuni, Hattori, Norifumi, Hayashi, Masamichi, Tanaka, Chie, Nakayama, Goro, Kodera, Yasuhiro
• Format: Journal Article
• Language: English
• Published: Singapore Springer Nature Singapore 01.08.2023
• Subjects: Medicine; Medicine & Public Health; Original Article; Surgery; Surgical Oncology; Neoadjuvant therapy; Esophageal squamous cell carcinoma; Prognosis; Systemic immune-inflammation index
• ISSN: 0941-1291; 1436-2813; 1436-2813
• DOI: 10.1007/s00595-023-02658-0

Purposes Systemic inflammation and immune status play a critical role in the development and progression of cancers. We evaluated the clinical significance of the preoperative systemic immune-inflammation index (SII) for predicting the long-term outcomes of patients who received neoadjuvant therapy...